News

New Webinar “SEERies” Features NCI Analytic Tools for Surveillance, Epidemiology, and End Results (SEER) Data and Other Cancer Surveillance Data

To reduce the cancer burden among the U.S. population, the Surveillance, Epidemiology, and End Results (SEER) program provides cancer researchers, data scientists, and the like with cancer statistics, databases, and software for their research and analysis. To learn more about some of these resources, attend any or all of these upcoming webinars (hosted by the NCI Surveillance Research Program, part of NCI’s Division of Cancer Control and Population Sciences).

SEER and SEER*Stat Overview | October 14, 2021, 1:00 p.m.–3:00 p.m. ET

Topic covered will include:

  • an overview of the SEER program, SEER data.
  • an overview of SEER*Stat and its new GUI.
  • sessions on case listing, frequencies, and rates.
  • graphical capabilities in new SEER*Stat.
  • databases (Research vs. Research Plus).
  • case selection.
  • how to create user-defined variables and merged variables.
  • how to export the data.

Survival | October 28, 2021, 1:00 p.m.–3:00 p.m. ET

Topics covered will include:

  • the 5 types of survival.
    • Net vs. Crude
    • Relative survival vs. cause-specific survival
  • age-standardized survival.
  • period survival.
  • conditional survival.

SEER Variables | November 2, 2021, 1:00 p.m.–3:00 p.m. ET

Topics covered will include:

  • variables by categories: demographics, tumor characteristics, treatment, follow-up, and dates.
  • cancer type recodes.
  • cancer type-specific variables.
  • staging definitions and caution when using them over time.
  • county attributes (i.e., not at the individual level but at the county level).

Delay and Joinpoint | November 4, 2021, 1:00 p.m.–3:00 p.m. ET

Topics covered will include:

  • an overview of methods to estimate adjustment delay in reporting.
  • how to use SEER*Stat to calculate delay-adjusted incidence rates.
  • a summary of the Joinpoint method.
  • how to use Joinpoint to calculate trends in delay adjusted and not delay adjusted incidence rates.

SEER currently collects and publishes cancer incidence and survival data from population-based cancer registries covering almost 47.9% of the U.S. population. NIH-backed organizations are using SEER data to better match people with clinical trials that are most likely to work for them.

These webinars will include a Q&A session. Webinars will also be recorded and posted on the SEER program website for later reference. If you are an individual with a disability who needs reasonable accommodations to participate in this event, please contact Trish Murphy at least 5 business days before the event to discuss your accommodation request.